The Board of Regents of the University of Texas System
发明人:
Wilkie Thomas M.,Brekken Rolf A.
申请号：
US201514920195
公开号：
US9986723(B2)
申请日:
2015.10.22
申请国别(地区):
美国
年份:
2018
代理人:
Parker Highlander PLLC
摘要：
The present disclosure relates to methods for screening compounds for treating pancreatic ductal adenocarcinoma (PDA) using a mouse model with an Rgs16::GFP reporter. Also described are combination therapies for treating pancreatic ductal adenocarcinoma (PDA) using taxanes, gemcitabine and an Axl kinase inhibitor.
